Bevacizumab Improves Quality of Life in Patients with Recurrent Glioblastoma

<table>Impact of BEV in the independent living score. Time of functional independence is increased after BEV. The mean Independent Living Score (ILS) in patients treated with BEV compared to those in the No-BEV group is nearly double. Results are depicted as mean ± SD.</table>

Chemotherapy Research and Practice

fig4

Figure 4

Figure 4: Bevacizumab Improves Quality of Life in Patients with Recurrent Glioblastoma 